This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          
HOPE LOGO

Oncology

Takeda presents data from Phase III TOURMALINE-MM1 study for NINLARO®
Takeda presents data from Phase III TOURMALINE-MM1 study for NINLARO®
Read more
EC approves Amgen’s Blincyto® for the treatment of adults with acute lymphoblastic leukaemia
EC approves Amgen’s Blincyto® for the treatment of adults with acute lymphoblastic leukaemia
Read more
EC approves Kyprolis® for combination use in the treatment of relapsed multiple myeloma
EC approves Kyprolis® for combination use in the treatment of relapsed multiple myeloma
Read more
Amgen receives CHMP positive opinion for Imlygic
Amgen receives CHMP positive opinion for Imlygic
Read more
New online Smart Map shows progress in UK lung cancer care
New online Smart Map shows progress in UK lung cancer care
Read more
GE automated breast ultrasound examination adapts to individual patient needs
GE automated breast ultrasound examination adapts to individual patient needs
Read more
TAILORx study shows low Oncotype DX® Recurrence Score® patients were breast cancer relapse-free
TAILORx study shows low Oncotype DX® Recurrence Score® patients were breast cancer relapse-free
Read more
Perjeta® gets regulatory green light for use in early HER2-positive breast cancer prior to surgery
Perjeta® gets regulatory green light for use in early HER2-positive breast cancer prior to surgery
Read more
Immunotherapy atezolizumab limits disease progression for patients with mUBC
Immunotherapy atezolizumab limits disease progression for patients with mUBC
Read more
Understanding immuno-oncology in kidney cancer
Understanding immuno-oncology in kidney cancer
Read more
Oxford starts on biggest ever genetic recruitment project
Oxford starts on biggest ever genetic recruitment project
Read more
Newcastle gets £5 million to boost drug development
Newcastle gets £5 million to boost drug development
Read more
Lymphatic mapping and tumour localisation
Lymphatic mapping and tumour localisation
Read more
Study has found that there are five kinds of prostate cancer
Study has found that there are five kinds of prostate cancer
Read more
Genmab announces European regulatory submission for ofatumumab for relapsed CLL
Genmab announces European regulatory submission for ofatumumab for relapsed CLL
Read more
Planmed launches the new Planmed Clarity™ 3D system
Planmed launches the new Planmed Clarity™ 3D system
Read more
Proton Partners International acquires site for first proton beam therapy cancer treatment centre
Proton Partners International acquires site for first proton beam therapy cancer treatment centre
Read more

Popular articles

Consultant pay reform package agreed in principle with UK Government
HPV vaccine has changed strains in circulation ‘impacting screening plans’, Finnish study shows
New policy to support wellbeing of doctors in Europe published by CPME





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×